Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 21c, provides outlook

Privia Health Group, Inc. (NASDAQ: PRVA) reported Q4 EPS of $0.25, $0.21 better than the analyst estimate of $0.04. Revenue for the quarter came in at $541.17 million versus the consensus estimate of $515.86 million.

2026 Financial and Business Outlook

Privia Health’s key areas of focus in 2026 include:

Organic provider growth in existing states;
Continuing to perform in value-based risk arrangements for positive margin contribution in challenging Medicare Advantage (MA) market;
Achieving operating leverage to drive Adjusted EBITDA growth, and converting approximately 80% of Adjusted EBITDA to Free Cash Flow; and
Pursuing disciplined and strategic business development activities to enter new states and expand in existing states to increase overall addressable market.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink